| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
7,411 |
6,173 |
$591K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
4,224 |
3,666 |
$481K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,440 |
2,115 |
$188K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,559 |
1,327 |
$57K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
742 |
636 |
$30K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
239 |
213 |
$24K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
5,326 |
4,435 |
$18K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
400 |
364 |
$13K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
555 |
497 |
$12K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
1,137 |
849 |
$11K |
| 87535 |
|
704 |
519 |
$11K |
| 87538 |
|
704 |
518 |
$11K |
| 87516 |
|
708 |
522 |
$10K |
| 87521 |
Neg quan hep c or qual rna |
705 |
517 |
$10K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
607 |
484 |
$9K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
606 |
483 |
$9K |
| 87641 |
|
447 |
329 |
$6K |
| 87653 |
|
358 |
286 |
$6K |
| 87500 |
|
359 |
287 |
$6K |
| 87640 |
|
305 |
258 |
$4K |
| 87481 |
|
448 |
329 |
$4K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
81 |
75 |
$3K |
| 80053 |
Comprehensive metabolic panel |
542 |
411 |
$3K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
670 |
499 |
$2K |
| 80061 |
Lipid panel |
426 |
309 |
$2K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
47 |
25 |
$2K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
77 |
69 |
$2K |
| 87428 |
|
88 |
79 |
$2K |
| 96127 |
|
274 |
238 |
$1K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
40 |
12 |
$1K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
47 |
13 |
$898.74 |
| 83735 |
|
522 |
397 |
$716.73 |
| 36415 |
Collection of venous blood by venipuncture |
297 |
276 |
$517.50 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
87 |
78 |
$516.75 |
| 0004A |
|
12 |
12 |
$480.00 |
| 99441 |
|
81 |
71 |
$98.62 |
| 81003 |
|
48 |
45 |
$91.63 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
46 |
45 |
$69.59 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
429 |
374 |
$54.20 |
| 83721 |
|
30 |
17 |
$52.34 |
| 82310 |
|
28 |
15 |
$41.30 |
| 82374 |
|
28 |
15 |
$39.00 |
| 82540 |
|
28 |
15 |
$37.10 |
| 84520 |
|
28 |
15 |
$31.60 |
| 82947 |
|
28 |
15 |
$31.40 |
| 83718 |
|
21 |
13 |
$13.10 |
| 84478 |
|
21 |
13 |
$9.18 |
| 82565 |
|
33 |
27 |
$9.13 |
| 96160 |
|
20 |
12 |
$8.31 |
| 82465 |
|
21 |
13 |
$6.96 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
71 |
63 |
$0.00 |
| 82040 |
|
18 |
13 |
$0.00 |
| 3008F |
|
17 |
14 |
$0.00 |
| 99452 |
|
14 |
13 |
$0.00 |
| 84075 |
|
18 |
13 |
$0.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
32 |
31 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
412 |
361 |
$0.00 |
| 84460 |
|
18 |
13 |
$0.00 |
| 3725F |
|
243 |
210 |
$0.00 |
| 82248 |
|
18 |
13 |
$0.00 |
| 84450 |
|
18 |
13 |
$0.00 |
| 82247 |
|
18 |
13 |
$0.00 |
| 84155 |
|
18 |
13 |
$0.00 |